Cosmecca Korea Q1 Consolidated Revenue 185.1B (+56%), Operating Profit 21.9B, Credit Rating Upgraded, Additional Stake in Ingwood Lab

Consolidated Q1 2026 revenue 185.1B KRW (+56.4% YoY), operating profit 21.9B, net profit attributable to parent 21.1B
Standalone revenue 142.2B (+94.2% YoY), operating profit 17.8B, net profit 16.4B
Acquired additional 16.67% stake in Ingwood Lab via tender offer (~43.2B KRW), increasing ownership to 66.67%
Consolidated debt ratio rose to 117.01% from 87.91% at year-end due to increased borrowings
Credit rating upgraded to A- by NICE D&B in April 2026
Declared cash dividend of 370 won per share for FY2025 (~3.95B KRW total)
Amended articles to establish audit committee and raise independent director ratio to at least 1/3, improving governance
In March 2026, developed world-first water-in-water emulsion sunscreen, published in Chemical Engineering Journal
Pending lawsuit: Cosmax Neo claims damages of 29 million won (first trial, immaterial)